Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

533
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
533

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observational Study Profiling the Immune Microenvironment of Pregnancy-associated Melanoma.

The American Journal of dermatopathology·2026
Same author

Topical Antibiotic Monotherapy Only Provides Mild Benefit for Patients with Acne Vulgaris: A Systematic Review and Network Meta-analysis.

Clinical drug investigation·2026
Same author

Acral Intravascular Papillary Endothelial Hyperplasia Mimicking Melanoma on Dermoscopy.

Acta dermato-venereologica·2026
Same author

Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial.

The British journal of dermatology·2026
Same author

Evidence of a Therapeutic Window for TNF-α Inhibitor and Intravenous Immunoglobulin Benefits in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: A Multicenter 6-Year Retrospective Study.

The journal of allergy and clinical immunology. In practice·2026
Same author

Global Trends and Future Predictions of Psoriasis Burden: Insights from the GBD 2021 Study.

Psoriasis (Auckland, N.Z.)·2025

Related Experiment Video

Updated: Nov 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K

Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning.

Zefan Liu1, Guannan Zhu1, Xian Jiang1

  • 1Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.

Frontiers in Oncology
|December 17, 2020
PubMed
Summary

Machine learning accurately predicts gallbladder cancer (GBC) survival using CT scans. Radiomics features from pre-treatment images, analyzed with LASSO and Random Forest, identified high-risk patients for improved GBC outcome prediction.

Keywords:
gallbladder cancermachine learningprognosisradiomicsrandom forest

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

363
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K

Related Experiment Videos

Last Updated: Nov 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

363
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K

Area of Science:

  • Radiomics and Medical Imaging
  • Machine Learning in Oncology
  • Cancer Prognostics

Background:

  • Gallbladder cancer (GBC) poses a significant challenge in oncology.
  • Accurate prediction of GBC patient survival is crucial for treatment planning.
  • Current prognostic models may benefit from advanced analytical techniques.

Purpose of the Study:

  • To develop a machine learning classifier for predicting overall survival in GBC patients.
  • To leverage pre-treatment CT imaging features for survival prediction.
  • To integrate radiomic features with clinical information for enhanced prognostic accuracy.

Main Methods:

  • Retrospective analysis of 141 pathologically confirmed GBC patients.
  • Manual segmentation of tumor lesions on pre-treatment CT scans.
  • Extraction of radiomic features using the LIFEx package.
  • Feature selection and model optimization using LASSO and Random Forest algorithms.
  • Multivariate COX regression incorporating clinical factors for survival prediction.

Main Results:

  • Fifteen CT-derived radiomic features were selected.
  • Key features included GLZLM-HGZE, GLCM-homogeneity, and NGLDM-coarseness.
  • A CT-based model showed a hazard ratio of 1.462 (95% CI: 1.014-2.107).
  • High-risk groups identified by the model exhibited significantly poorer survival (P = 0.012).
  • The final model achieved AUC values of 0.79 (test set) and 0.73 (validation set) for 3-year survival prediction.

Conclusions:

  • Radiomics analysis, utilizing LASSO and Random Forest, can effectively predict GBC survival outcomes.
  • Machine learning models integrating CT-based radiomic features offer a promising tool for GBC prognostication.
  • This approach may aid in stratifying patients and guiding clinical management decisions.